FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/11/047369 [Registered on: 16/11/2022] Trial Registered Prospectively
Last Modified On: 27/10/2022
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Single Arm Study 
Public Title of Study   Design and Development of decision support system for detection of breast cancer from Mammograms 
Scientific Title of Study   Design and Development of Deep Learning based system for detection of breast cancer from Digital Mammograms 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ashwini Amin 
Designation  Ph.D Research Scholor  
Affiliation  Manipal Institute of Technology 
Address  Department of Computer Science Engineering Academic Block 5 Manipal Institute of Technology(MIT), Eshwar Nagar, Manipal, Udupi, Karnataka-576104

Udupi
KARNATAKA
576104
India 
Phone  7411775862  
Fax    
Email  ashwini.amin@learner.manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Dinesh Acharya U 
Designation  Professor 
Affiliation  Manipal Institute of Technology 
Address  Department of Computer Science Engineering Academic Block 5 Manipal Institute of Technology(MIT), Eshwar Nagar, Manipal, Udupi, Karnataka-576104

Udupi
KARNATAKA
576104
India 
Phone  9449367822  
Fax    
Email  dinesh.acharya@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Stanley Mathew 
Designation  Professor of Surgery 
Affiliation  Kasturba Medical College, Manipal 
Address  Department of Surgery, 3rd Floor, Smt. Sharadha Madhav Pai OPD, Kasturba Hospital

Udupi
KARNATAKA
576104
India 
Phone  08202923728  
Fax    
Email  stanley.mathew@manipal.edu  
 
Source of Monetary or Material Support  
Director, Manipal Institute of Technology, Eshwar Nagar, Manipal, Udupi, Karnataka-576104 
 
Primary Sponsor  
Name  Ashwini Amin 
Address  Manipal Institute of Technology(MIT), Eshwar Nagar, Manipal, Udupi, Karnataka-576104 
Type of Sponsor  Other [Private Institute of Technology] 
 
Details of Secondary Sponsor  
Name  Address 
Medical Superintendent  Kasturba Hospital, Madhavnagar, Manipal, Udupi, Karnataka-576104 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ashwini Amin  Kasturba Hospital, Manipal  PACS Room 2, Department of Radiodiagnosis, Ground Floor, Baliga Block, Kasturba Hospital, Manipal
Udupi
KARNATAKA 
7411775862

ashwini.amin@learner.manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
KMC and KH Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C508||Malignant neoplasm of overlappingsites of breast, (2) ICD-10 Condition: D249||Benign neoplasm of unspecified breast, (3) ICD-10 Condition: C509||Malignant neoplasm of breast of unspecified site,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Female 
Details  1. Patients who undergo bilateral mammography
2. Consenting individuals
3. Patients undergoing FNAC, biopsy or surgical excision for confirmation 
 
ExclusionCriteria 
Details  1. Patients below 18 years and above 99 years
2. Male Patients
3. Patients who have undergone only unilateral mammography
4. Patients who do not have cytological or histopathological confirmation of diagnosis 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Positive identification of malignant and benign lesions in the mammogram using deep learning model  30 days 
 
Secondary Outcome  
Outcome  TimePoints 
Identification of ideal parameters to incorporate into the CAD design  30 days 
 
Target Sample Size   Total Sample Size="5500"
Sample Size from India="5500" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/01/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Data collection not commenced. Publication is anticipated after data collection and analysis 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response (Others) -  Researchers whose proposed use of the data has been approved by an Institutional Ethics committee identified for this purpose, Editors of Journals and an appropriate Regulatory Authority

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response (Others) -  To gain access, data requestors will need to sign a data access agreement.

  6. For how long will this data be available start date provided 01-01-2027 and end date provided 01-01-2032?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - Nil
Brief Summary  

Female breast cancer has become the most often diagnosed type of cancer in the world and has become a major health concern across rural and urban areas in India nowadays. Asian women are more likely to have dense breasts than other women in the world. Dense breast tissue can make it more difficult to detect breast cancer and is also linked to an increased risk of breast cancer. Digital Mammography is a very useful technique for screening and is acknowledged as the most reliable method for detecting breast cancer at an early stage, but its accuracy is limited by the radiologists’ clinical experience.

To solve this problem a novel fully automated deep learning-based breast cancer computer-aided diagnosis system (CAD) enabled with a graphical user interface is proposed. Quantitative research will be conducted focusing on Digital Mammogram pre-processing, image segmentation to detect regions of interest, and classification of these images based on the Breast Imaging-Reporting and Data System (BI-RADS) using deep learning models. We propose to design a novel CAD system based on the digital mammograms available at Kasturba Hospital, Manipal Patient Archival System. 

In the pre-processing phase, the raw mammography images collected from the above database will be anonymized, the BI-RADS reports and the histopathology reports will be analyzed and information related to various lesions will be extracted from the reports. The final curated data will be further processed through image resizing, and conversion to other image formats for the purpose of readability by the program. The need for various de-noising and enhancement techniques will be studied using various performance evaluation parameters.

In the segmentation phase, the model will be developed to detect the Region of Interest (ROI) after removing the pectoral muscles from the mediolateral oblique (MLO) view and any other artifacts which will be identified after data collection. Various traditional segmentation models and deep learning-based segmentation models will be studied and the best model based on the performance metrics will be identified. In the classification phase, the segmented image will be split into training, validation, and testing set which will be tested on various deep-learning models. 

The best model based on the performance will be used as the final model for the prospective testing. In the prospective testing phase we will validate the CAD in patients who consent to participate in the study and will be undergoing mammography for clinical indications

 
Close